<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00535054</url>
  </required_header>
  <id_info>
    <org_study_id>06.11</org_study_id>
    <nct_id>NCT00535054</nct_id>
  </id_info>
  <brief_title>Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye Symptoms</brief_title>
  <official_title>An Open Study to Assess the Safety and Patients' Satisfaction Tears Again* in the Treatment of Dry Eye Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Trima, Israel Pharmaceutical Products</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Trima, Israel Pharmaceutical Products</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine safety and patients' satisfaction when using Tears
      Again to treat Dry Eye Symptoms.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Schirmer Test, Lissamine Green Test and BUT.</measure>
    <time_frame>On enrollment and one month later.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Questionaire</measure>
    <time_frame>One, three and four weeks after treatment commencement.</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">125</enrollment>
  <condition>Dry Eye Syndrome</condition>
  <arm_group>
    <arm_group_label>Tears Again</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects shall be treated with Tears Again.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tears Again</intervention_name>
    <description>Liposome Eye Spray</description>
    <arm_group_label>Tears Again</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Suffer from at least two of the following ocular symptoms: burning, stinging,
             excessive tearing, dryness, grittiness, foreign body sensation ( including patients
             suffering from blepharitis).

          -  Use artificial tears or any other treatment for these symptoms three or more times a
             day.

        Exclusion Criteria:

          -  Known hypersensitivity to Phenoxyethanol.

          -  Pregnant and lactating women.

          -  Receive other ophthalmic medication (except for eyelid hygiene preparations).

          -  Graft-versus-host disease patients.

          -  Participated during the last month in another clinical trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Zadok, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Ophthalmology, Assaf Harofeh Medical Center,</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Ophthalmology, Assaf Harofeh Medical Center,</name>
      <address>
        <city>Zerifin</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Lee S, Dausch S, Maierhofer G, Dausch D. [A new therapy concept for the treatment of dry eye--the usefulness of phospholipid liposomes]. Klin Monbl Augenheilkd. 2004 Oct;221(10):825-36. German.</citation>
    <PMID>15499517</PMID>
  </reference>
  <reference>
    <citation>Dausch D, Lee S, Dausch S, Kim JC, Schwert G, Michelson W. [Comparative study of treatment of the dry eye syndrome due to disturbances of the tear film lipid layer with lipid-containing tear substitutes]. Klin Monbl Augenheilkd. 2006 Dec;223(12):974-83. German.</citation>
    <PMID>17199193</PMID>
  </reference>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 23, 2007</study_first_submitted>
  <study_first_submitted_qc>September 24, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2007</study_first_posted>
  <last_update_submitted>February 7, 2010</last_update_submitted>
  <last_update_submitted_qc>February 7, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2010</last_update_posted>
  <responsible_party>
    <name_title>David Zadok, MD</name_title>
    <organization>Department of Ophthalmology, Assaf Harofeh Medical Center,Zerifin, Israel</organization>
  </responsible_party>
  <keyword>Dry Eye Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

